作者
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, Syamal Roy, Dipanjan Ghosh
发表日期
2021
来源
RSC advances
卷号
11
期号
27
页码范围
16711-16735
出版商
Royal Society of Chemistry
简介
At the end of 2019, a life threatening viral infection (COVID-19) caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported. This virus has spread worldwide in a short duration and forced the world to face unprecedented life and economic loss. To date, there are no known specific drugs to combat this virus and the process for new drug development is lengthy. Most promising candidates, which emerged as potential leads, were abandoned in the later phases of clinical trials. Repurposing of already approved drugs for other therapeutic applications can be done only after extensive testing for safety and efficacy. With no definite therapeutics in the horizon, natural products are in extensive use arbitrarily as anti-viral agents and immune boosters. For ages it has been known that most natural products possess potent anti-viral activity and it is no different for SARS-CoV …
引用总数
学术搜索中的文章